Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. Return on Invested Capital (ROIC)
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Invested Capital (ROIC) | 79.5% | (52.1%) | (115.7%) | (140.0%) | (99.5%) | (31.7%) | (26.4%) | (47.7%) | 104.4% | 36.9% | 23.7% | 25.8% | 25.2% | 27.1% | 45.6% | 32.3% | 44.4% | 119.8% | 53.1% | 30.8% |
Regeneron Pharmaceuticals, Inc. (REGN) Return on Invested Capital (ROIC) comparison analysis
REGN key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Regeneron Pharmaceuticals, Inc.'s Return on Invested Capital (ROIC)?
As of today, Microsoft Corp's last 12-month Return on Invested Capital (ROIC) is 26.7%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Invested Capital (ROIC) for Regeneron Pharmaceuticals, Inc. have been 48.7% over the past three years, and 46.7% over the past five years.
2) Is Regeneron Pharmaceuticals, Inc.'s Return on Invested Capital (ROIC) Good?
As of today, Regeneron Pharmaceuticals, Inc.'s Return on Invested Capital (ROIC) is 26.7%, which is higher than industry median of (123.1%). It indicates that Regeneron Pharmaceuticals, Inc.'s Return on Invested Capital (ROIC) is Good.